Alector Balance Sheet Health
Financial Health criteria checks 6/6
Alector has a total shareholder equity of $178.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $635.5M and $456.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$562.08m |
| Equity | US$178.91m |
| Total liabilities | US$456.59m |
| Total assets | US$635.49m |
Recent financial health updates
Here's Why We're Not Too Worried About Alector's (NASDAQ:ALEC) Cash Burn Situation
Sep 25
Here's Why We're Not Too Worried About Alector's (NASDAQ:ALEC) Cash Burn Situation
Jun 27Alector (NASDAQ:ALEC) Is In A Good Position To Deliver On Growth Plans
Jan 16We're Not Very Worried About Alector's (NASDAQ:ALEC) Cash Burn Rate
Sep 27Recent updates
Alector, Inc. (NASDAQ:ALEC) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 11Analysts Are Updating Their Alector, Inc. (NASDAQ:ALEC) Estimates After Its Full-Year Results
Mar 01The Market Doesn't Like What It Sees From Alector, Inc.'s (NASDAQ:ALEC) Revenues Yet As Shares Tumble 27%
Jan 19Alector: Good Data, Huge Cash, No Near Term Catalyst
Jan 16Here's Why We're Not Too Worried About Alector's (NASDAQ:ALEC) Cash Burn Situation
Sep 25Here's Why We're Not Too Worried About Alector's (NASDAQ:ALEC) Cash Burn Situation
Jun 27Analysts Are Betting On Alector, Inc. (NASDAQ:ALEC) With A Big Upgrade This Week
Mar 02Alector (NASDAQ:ALEC) Is In A Good Position To Deliver On Growth Plans
Jan 16Alector: Advancement Of Third Alzheimer's Drug Brings About Huge Potential
Oct 04AbbVie ends partnership with Alector for Alzheimer’s candidate
Jul 08Alector: Potential In Neurology And Cancer Treatments
Jun 14Need To Know: The Consensus Just Cut Its Alector, Inc. (NASDAQ:ALEC) Estimates For 2022
May 18Alector: Expect Phase 3 Data Next Year
Apr 16These Analysts Just Made An Downgrade To Their Alector, Inc. (NASDAQ:ALEC) EPS Forecasts
Feb 27Alector, Inc: A Newer Biotech Company With Big Potential
Jan 26Alector: The GSK Deal Is A Major Value Add
Oct 29We're Not Very Worried About Alector's (NASDAQ:ALEC) Cash Burn Rate
Sep 27This Just In: Analysts Are Boosting Their Alector, Inc. (NASDAQ:ALEC) Outlook for This Year
Aug 05New Forecasts: Here's What Analysts Think The Future Holds For Alector, Inc. (NASDAQ:ALEC)
Jul 06Financial Position Analysis
Short Term Liabilities: ALEC's short term assets ($581.4M) exceed its short term liabilities ($164.9M).
Long Term Liabilities: ALEC's short term assets ($581.4M) exceed its long term liabilities ($291.7M).
Debt to Equity History and Analysis
Debt Level: ALEC is debt free.
Reducing Debt: ALEC has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ALEC has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ALEC has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 11.7% each year